MicroRNA-15b in Extracellular Vesicles from Arsenite-Treated Macrophages Promotes the Progression of Hepatocellular Carcinomas by Blocking the LATS1-mediated Hippo Pathway
Junjie Li,Junchao Xue,Min Ling,Jing Sun,Tian Xiao,Xiangyu Dai,Qian Sun,Cheng,Haibo Xia,Yongyue Wei,Feng Chen,Qizhan Liu
DOI: https://doi.org/10.1016/j.canlet.2020.10.023
IF: 9.756
2021-01-01
Cancer Letters
Abstract:Arsenic, a human carcinogen, causes various human cancers, including those of the skin, lung, and liver. Hepatocellular carcinomas (HCCs), which have high mortality, are common malignancies worldwide. Tumor associated macrophages (TAMs), which are considered to be similar to M2-polarized macrophages, promote tumor invasion and progression. Small non-coding RNAs (miRNAs) regulate expression of genes involved in progression of various malignancies. Extracellular vesicles (EVs), as mediators of cell communication, pass specific miRNAs directly from TAMs to tumor cells, promoting tumor pathogenesis and metastasis. In HCCs, large tumor suppressor kinase 1 (LATS1), functions as a tumor suppressor. However, the molecular mechanism by which miRNA modulates LATS1 expression in HCCs remains unclear. The results show that exposure to arsenite, increased miR-15b levels and induced M2 polarization of THP-1 cells. Elevated levels of miR-15b were transferred from arsenite-treated-THP-1 (As-THP-1) cells to HCC cells via miR-15b in EVs inhibited activation of the Hippo pathway by targeting LATS1, and was involved in promoting the proliferation, migration, and invasion of HCC cells. In conclusion, miR-15b in EVs from As-THP-1 cells is transferred to HCC cells, in which it targets and downregulates LATS1 expression and promotes the proliferation, migration, and invasion of HCC cells.